MicroRNA expression in acute myeloid leukemia
- PMID: 20425419
- DOI: 10.1007/s11899-009-0012-7
MicroRNA expression in acute myeloid leukemia
Abstract
Acute myeloid leukemia (AML) is a group of diseases that are very heterogeneous with regard to cytogenetic aberrations, gene mutations, and changes in expression of numerous genes. A new class of genes known as microRNAs recently was found to be involved in myeloid leukemogenesis. These genes are transcribed into regulatory, noncoding RNAs that control mRNA and protein expression of target genes. Genome-wide analyses of microRNA expression have revealed signatures associated with selected cytogenetic and molecular subsets of AML and have led to the recognition of previously unreported molecular pathways involved in myeloid leukemogenesis. In cytogenetically normal AML, microRNA-expression profiling has also provided prognostic information in addition to that obtained from cytogenetics and analyses of gene mutations and aberrant gene expression. This article reviews recent studies that were focused on the alterations of microRNA expression in AML and their diagnostic and prognostic significance.
Similar articles
-
Molecular signatures in acute myeloid leukemia.Curr Opin Hematol. 2009 Mar;16(2):64-9. doi: 10.1097/MOH.0b013e3283257b42. Curr Opin Hematol. 2009. PMID: 19468266 Free PMC article. Review.
-
The prognostic and functional role of microRNAs in acute myeloid leukemia.Blood. 2011 Jan 27;117(4):1121-9. doi: 10.1182/blood-2010-09-191312. Epub 2010 Nov 2. Blood. 2011. PMID: 21045193 Free PMC article. Review.
-
MicroRNA expression profiling in relation to the genetic heterogeneity of acute myeloid leukemia.Blood. 2008 May 15;111(10):5078-85. doi: 10.1182/blood-2008-01-133355. Epub 2008 Mar 12. Blood. 2008. PMID: 18337557
-
A novel miR-375-HOXB3-CDCA3/DNMT3B regulatory circuitry contributes to leukemogenesis in acute myeloid leukemia.BMC Cancer. 2018 Feb 13;18(1):182. doi: 10.1186/s12885-018-4097-z. BMC Cancer. 2018. PMID: 29439669 Free PMC article.
-
Clinical relevance of mutations and gene-expression changes in adult acute myeloid leukemia with normal cytogenetics: are we ready for a prognostically prioritized molecular classification?Blood. 2007 Jan 15;109(2):431-48. doi: 10.1182/blood-2006-06-001149. Epub 2006 Sep 7. Blood. 2007. PMID: 16960150 Free PMC article. Review.
Cited by
-
Aberrant Expression of the miR-181b/miR-222 after Hematopoietic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia.Indian J Hematol Blood Transfus. 2019 Jul;35(3):446-450. doi: 10.1007/s12288-018-01066-6. Epub 2019 Jan 21. Indian J Hematol Blood Transfus. 2019. PMID: 31388255 Free PMC article.
-
The Diagnostic and Prognostic Role of microRNA in Colorectal Cancer - a Comprehensive review.J Cancer. 2013;4(3):281-95. doi: 10.7150/jca.5836. Epub 2013 Mar 20. J Cancer. 2013. PMID: 23459799 Free PMC article.
-
Distinctive microRNA signature is associated with the diagnosis and prognosis of acute leukemia.Med Oncol. 2012 Dec;29(4):2323-31. doi: 10.1007/s12032-011-0140-5. Epub 2011 Dec 31. Med Oncol. 2012. PMID: 22209839
-
MicroRNAs: promising chemoresistance biomarkers in gastric cancer with diagnostic and therapeutic potential.World J Gastroenterol. 2014 Oct 14;20(38):13658-66. doi: 10.3748/wjg.v20.i38.13658. World J Gastroenterol. 2014. PMID: 25320504 Free PMC article. Review.
-
Over-expression of mir-181a-3p in serum of breast cancer patients as diagnostic biomarker.Mol Biol Rep. 2024 Feb 27;51(1):372. doi: 10.1007/s11033-024-09272-4. Mol Biol Rep. 2024. PMID: 38411870
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources